Presentations

A Focus on the Background, Utilization and Post- Marketing Surveillance Initiatives in the US
Mark J. Cziraky
26 December, 2018
Blood and Marrow Transplant Pharmacist Introduction to Pharmaceutical Care
Julian Lindsay
24 December, 2018
her2 cd3 bispecific
Bella Smith
13 December, 2018
IP Framework for Pharmaceuticals In Europe: Is It Really Necessary?
I-Com
12 December, 2018
Safety Evaluation of 2
Maja Janas PhD
07 December, 2018
Diseases of Aging: New Therapeutic Solution by Biotech Specialized
Stanislas Veillet...
22 November, 2018
Research on Stem Cells The Conference 2018
Understanding Ste...
14 November, 2018
Robust and Durable Target Silencing in the CNS with siRNA Conjugates
Alnylam Pharmaceu...
03 November, 2018
Protect patients, not patents How medicine prices are leading to two-tiered healthcare in Switzerland
Public Eye
29 October, 2018
Impact of a Multidisciplinary Pain Management Program on Patient Care Utilization and Cost of Care
Daniel D. Maeng P...
27 October, 2018
CAR T-CELL THERAPIES Scientific and Policy Perspectives
Viviana Galli, Tu...
23 October, 2018
Advanced Biopharmaceutical Technology Platform: Role of DCB to the Biotech Industry in Taiwan
Wei-Kuang Chi PhD...
22 October, 2018
Compulsory Licensing of Pharmaceutical Patents in the Russian Federation Threatens Foreign and Domestic Drug Developers
Bruce McDonald, V...
21 October, 2018
The Benefits of Biosimilar Medicines
IGBA
20 October, 2018
MDR Designation Process of Notified Bodies
Andrea Johmann Ph...
18 October, 2018
Innovative Pharmaceutical R&D in China: Status and Trends
Peng Wang PhD
15 October, 2018
Medicines Safety Programme Overview
Bruce Warner PhD
08 October, 2018
How Big Pharma and Academia Collaborate?
Patricia Sansilve...
03 October, 2018
Factors Affecting the Procurement of Pharmaceutical Drugs: A Case Study of Narok County Referral Hospital, Kenya
Joy Muhia, Lynn W...
01 October, 2018
Regulatory Experiences with Precision Health
Kelly Robinson
28 September, 2018